The hidden impact of COVID-19 treatment strategies on the spread of Clostridioides difficile infection
Acta Pharmaceutica · 2025
DOI: 10.2478/acph-2025-0037 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Acta Pharmaceutica, 2025. Verfasst von Ivana El Hassouni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, University of Mostar 88000 Mostar, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Clostridium Infections, COVID-19, COVID-19 Drug Treatment. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The COVID-19 pandemic introduced substantial changes to clinical practice, including widespread antibiotic use. These changes raised concerns about a potential rise in healthcare-associated infections, particularly Clostri dioi des difficile infection (CDI). This study aimed to investigate the hidden impact of COVID-19 treatment strategies on the incidence of CDI, with a specific focus on antibiotic use, advanced age, comorbidities, and the administration of proton pump inhibitors (PPIs) and corticosteroids. A retrospective observational study was conducted using anonymised patient data from the University Clinical Hospital Mostar. The number of CDI cases significantly increased during the COVID-19 peak in 2021, showing a perfect positive correlation with COVID-19 incidence ( ρ = 1.0, p < 0.05). Antibiotic use was strongly associated with CDI (69 % vs. 12 %; p < 0.05), as was advanced age (≥ 65 years; 71 %; p < 0.05). The combined use of proton pump inhibitors and corticosteroids was significantly more frequent in the CDI group (54 % vs. 24 %; p < 0.05). The findings highlight how COVID-19 treatment strategies can unintentionally raise CDI risk, stressing the need for prudent antibiotic use, careful drug management and targeted prevention for elderly and high-risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, University of Mostar 88000 Mostar, Bosnia and Herzegovina.
- Pharmacy Health Institution Matić Ljubuški, 88320 Ljubuški, Bosnia and Herzegovina.
- Faculty of Food and Technology, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
- University Clinical Hospital Mostar, 88000 Mostar, Bosnia and Herzegovina.
- School of Medicine, University of Mostar 88000 Mostar, Bosnia and Herzegovina.
- Faculty of Health Studies, University of Mostar, 88000 Mostar, Bosnia and Herzegovina.
Zitieren
APA
Hassouni, I. E., Kondža, M., Tomić, I., Ivančić, I., Zeljko, I., & Brizić, I. (2025). The hidden impact of COVID-19 treatment strategies on the spread of Clostridioides difficile infection. Acta Pharmaceutica. https://doi.org/10.2478/acph-2025-0037
Vancouver
Hassouni IE, Kondža M, Tomić I, Ivančić I, Zeljko I, Brizić I. The hidden impact of COVID-19 treatment strategies on the spread of Clostridioides difficile infection. Acta Pharmaceutica. 2025. doi:10.2478/acph-2025-0037
BibTeX
@article{Hassouni2025,
author = {Hassouni, Ivana El and Kondža, Martin and Tomić, Ivan and Ivančić, Ivona and Zeljko, Ivan and Brizić, Ivica},
title = {The hidden impact of COVID-19 treatment strategies on the spread of Clostridioides difficile infection},
journal = {Acta Pharmaceutica},
year = {2025},
doi = {10.2478/acph-2025-0037}
}
EUVIMED